Pradaxa

Generic name: Dabigatran
Drug class: Thrombin inhibitors

Usage of Pradaxa

Pradaxa (dabigatran) belongs to a class of anticoagulant medications called direct thrombin inhibitors. Dabigatran works by preventing blood clots from forming in the body.

Pradaxa is used to treat blood clots deep in the body (deep vein thrombosis, DVT) and lungs (pulmonary embolism, PE) in adults who have received blood thinners by injection for 5 to 10 days.

Pradaxa is used to treat blood clots in children aged 3 months to less than 18 years of age who have been treated with an injectable blood thinner for at least 5 days.

Pradaxa is used in adults and children aged 3 months to less than 18 years of age to lower the risk of a blood clot coming back after receiving treatment for blood clots.

Pradaxa is also used after hip replacement surgery to prevent a blood clot deep in the body (deep vein thrombosis, DVT) or lungs (pulmonary embolism, PE).

Pradaxa is also used to lower the risk of stroke and blood clots in adults with atrial fibrillation (a heart rhythm disorder). This medicine is used when the atrial fibrillation is not caused by a heart valve problem.

Pradaxa side effects

Get emergency medical help if you have signs of an allergic reaction to Pradaxa: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Also seek emergency medical attention if you have symptoms of a spinal blood clot: back pain, numbness, tingling, muscle weakness in your lower body, or loss of bladder or bowel control.

Pradaxa may cause serious side effects. Call your doctor at once if you have:

bruising or bleeding that will not stop (nosebleeds, bleeding gums, heavy menstrual or vaginal bleeding);

headache, weakness, dizziness, or feeling like you might pass out;

bloody or tarry stools, coughing up blood or vomit that looks like coffee grounds;

urine that looks red, pink, or brown; or

unexpected pain, joint pain or swelling.

Common Pradaxa side effects include:

stomach pain or discomfort;

upset stomach, burning;

bleeding;

heavy menstrual bleeding; or

nausea, vomiting, diarrhea.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Pradaxa

You should not take Pradaxa if you are allergic to dabigatran, or if you have:

a mechanical prosthetic heart valve; or

active bleeding from a surgery, injury, or other cause.

Dabigatran can cause a serious blood clot if you undergo a procedure such as a spinal tap or receive spinal anesthesia (epidural). This type of blood clot could cause permanent or long-term paralysis.

Pradaxa can make it easier for you to bleed, even from a minor injury. Call your doctor if you have bleeding that will not stop.

To make sure Pradaxa is safe for you, tell your doctor if you have ever had:

a genetic spinal defect;

a thin tube (catheter) placed in your back to give you certain medicine;

a history of problems with your spine or a spinal surgery;

a history of difficult or repeated spinal taps;

bleeding problems;

a stomach ulcer or bleeding in your stomach or intestines;

take certain other medicines that can increase bleeding risk;

antiphospholipid syndrome, an immune system disorder that increases the risk of blood clots;

plan for surgery, or a medical or a dental procedure; or

kidney disease.

It is not known if dabigatran will harm an unborn baby. Taking Pradaxa during pregnancy may cause bleeding in the mother or the unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

You should not breastfeed while taking dabigatran.

Relate drugs

How to use Pradaxa

Usual Adult Dose of Pradaxa for Deep Vein Thrombosis -- Prophylaxis:

Recommended doses: 150 mg orally twice a day.

Usual Adult Dose for Prevention of Thromboembolism in Atrial Fibrillation:

Recommended doses: 150 mg orally twice a day Comments: Generally, the extent of anticoagulation does not need to be assessed with this drug; however, when necessary, use aPTT or ECT, and not INR to assess anticoagulant activity. Uses: Reduction of risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation; treatment of deep venous thrombosis and pulmonary embolism in patients who have been treated with a parenteral anticoagulant for 5 to 10 days; reduction in the risk of recurrence of deep venous thrombosis and pulmonary embolism in patients who have been previously treated.

Usual Adult Dose of Pradaxa for Deep Vein Thrombosis/Pulmonary Embolism Prophylaxis Following Hip Replacement Surgery:

110 mg orally 1 to 4 hours after surgery and after hemostasis has been achieved, then 220 mg orally once a day for 28 to 35 days Comments: If this drug is not started on the day of surgery, initiate treatment with 220 mg orally once a day after hemostasis has been achieved. Use: For the prophylaxis of DVT and PE in adult patients who have undergone hip replacement surgery.

Usual Pediatric Dose of Pradaxa for Venous Thromboembolism:

Weigh-based dosage: -11 kg to less than 16 kg: 75 mg twice daily -16 kg to less than 26 kg: 110 mg twice daily -26 kg to less than 41 kg: 150 mg twice daily -41 mg to less than 61 kg: 185 mg twice daily -61 kg to 81 kg: 220 mg twice daily -81 kg or greater: 260 mg twice daily Comments: -This drug is to be used in children 8 years old or older that can swallow a capsule. -In treatment of VTE, treatment should be initiated following treatment with a parenteral anticoagulant for at least 5 days. For reduction of VTE recurrence, initiate treatment following previous treatment. -The concomitant treatment of this drug with P-gb inhibitors has not been studied in children and may increase the exposure to this drug. Uses: -For the treatment of venous thromboembolic events (VTE) in pediatric patients 8 and older who have been treated with a parenteral anticoagulant for at least 5 days. -To reduce the risk of recurrence of VTE in pediatric patients 8 and older who have been previously treated.

Warnings

Pradaxa can cause you to bleed more easily. Call your doctor at once if you have: bleeding gums, nosebleeds, heavy menstrual periods or abnormal vaginal bleeding, blood in your urine, bloody or tarry stools, coughing up blood or vomit that looks like coffee grounds.

Many other drugs can increase your risk of bleeding when used with dabigatran. Tell your doctor about all medicines you have recently used.

Pradaxa can cause a very serious blood clot around your spinal cord if you undergo a spinal tap or receive spinal anesthesia (epidural), especially if you have a genetic spinal defect, if you have a spinal catheter in place, if you have a history of spinal surgery or repeated spinal taps, or if you are also using other drugs that can affect blood clotting. This type of blood clot can lead to long-term or permanent paralysis.

Get emergency medical help if you have symptoms of a spinal cord blood clot such as back pain, numbness or muscle weakness in your lower body, or loss of bladder or bowel control.

Do not stop taking Pradaxa without first talking to your doctor. Stopping suddenly can increase your risk of blood clot or stroke.

What other drugs will affect Pradaxa

Tell your doctor about all your current medicines. Many drugs can interact with dabigatran, especially:

dronedarone;

rifampin;

ketoconazole;

medicine used to prevent blood clots - enoxaparin, warfarin, heparin, clopidogrel, dipyridamole, prasugrel, and others; or

NSAIDs (nonsteroidal anti-inflammatory drugs) - aspirin, ibuprofen (Advil, Motrin), naproxen (Aleve), celecoxib, diclofenac, indomethacin, meloxicam, and others.

This list is not complete and many other drugs may interact with dabigatran. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.